Skip to main content

Echothiophate iodide ophthalmic Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Oct 29, 2021.

Echothiophate iodide ophthalmic is also known as: Phospholine Iodide

Echothiophate iodide ophthalmic Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

This drug should be used during pregnancy only if clearly needed and the benefit outweighs the risk to the fetus.

US FDA pregnancy category: Not assigned

Comments: Insufficient data available on use of this drug in pregnant women to inform a drug-related risk.

See references

Echothiophate iodide ophthalmic Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available


-This drug is a quaternary ammonium compound; it is not likely to pass into the breast milk or reach the bloodstream of the infant.

See references

References for pregnancy information

  1. "Product Information. Phospholine Iodide (echothiophate iodide ophthalmic)." Wyeth Laboratories (2014):

References for breastfeeding information

  1. "Product Information. Phospholine Iodide (echothiophate iodide ophthalmic)." Wyeth Laboratories (2014):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.